Cargando…
TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
Agonists for TLR9 and Stimulator of IFN Gene (STING) act as vaccine adjuvants that induce type-1 immune responses. However, currently available CpG oligodeoxynucleotide (ODN) (K-type) induces IFNs only weakly and STING ligands rather induce type-2 immune responses, limiting their potential therapeut...
Autores principales: | Temizoz, Burcu, Kuroda, Etsushi, Ohata, Keiichi, Jounai, Nao, Ozasa, Koji, Kobiyama, Kouji, Aoshi, Taiki, Ishii, Ken J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671267/ https://www.ncbi.nlm.nih.gov/pubmed/25529558 http://dx.doi.org/10.1002/eji.201445132 |
Ejemplares similares
-
Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019) -
Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells
por: Kitahata, Yuji, et al.
Publicado: (2016) -
TLR2-independent induction and regulation of chronic intestinal inflammation
por: Boulard, Olivier, et al.
Publicado: (2010) -
Properdin and factor H production by human dendritic cells modulates their T‐cell stimulatory capacity and is regulated by IFN‐γ
por: Dixon, Karen O., et al.
Publicado: (2017) -
Human β‐defensin 3 increases the TLR9‐dependent response to bacterial DNA
por: McGlasson, Sarah L., et al.
Publicado: (2017)